Anti DVT prophylaxis for varicose vein procedures

Tamara Everington graduated in 1993 from the Royal Free Hospital School of Medicine in London. Her postgraduate training in medicine in London was complemented by a PhD exploring molecular signalling pathways awarded by University College in 2006. Tamara practices as a haematology consultant subspecialising in haemostasis and thrombosis and is an active researcher. She contributed to the design & delivery of the GAPS study exploring the value of graduated compression stockings in VTE prevention which has now closed and published, and is now working with the same group on the CHAPS study exploring the value of GCS in DVT treatment. She is committed to delivering operational excellence in medicine and has played leading roles in the national VTE exemplar and AF anticoagulation optimisation programmes which have delivered measurable reductions in morbidity and mortality from hospital associated thrombosis and stroke. She is also the clinical lead for digital transformation within Hampshire Hospitals NHS Foundation Trust and the local region seeking to improve delivery of clinical care with the support of modern technology.

Professor Bruce Campbell was appointed consultant vascular surgeon to the Royal Devon and Exeter Hospital in 1986.  Since 2016 he has been an honorary consultant there and has a venous practice at Exeter Medical.  He has published and spoken very widely on venous and arterial disease and is an Honorary Professor at the University of Exeter Medical School. 

He spent several years on the Council of the Vascular Society; he was Honorary Secretary 1998-2002; and inaugural Chair of the Professional Standards Committee (2002-6).  He was on the Council of the Venous Forum at that time and re-joined the Venous Forum Council by invitation in 2016.  He has edited the Technical Section of the Annals of the Royal College of Surgeons since 2001.

Bruce Campbell chaired the National Institute for Health and Care Excellence (NICE) Advisory Committees on Interventional procedures 2002-15 and on Medical Technologies 2009-15. He is currently a Non-Executive Director of the UK Medicines and Healthcare products Regulatory Agency (MHRA). 

Mr Nyamekye works as consultant vascular and endovascular surgeon in Worcestershire (since 2000).

He is past member of the Council of the Vascular Society of Great Britain & Ireland and served on the executive committee of Venous Forum of the Royal Society of Medicine (2010-2018) and is immediate past president of the Forum (2016-2018). He serves on the editorial board of Phlebology and is a member of the scientific committee of the Societe Francais de Phlebologie. He was awarded Honorary Life Membership of the SFP in 2019.

Mr Nyamekye has a long standing interest in the poorly researched area of anti-VTE prophylaxis for patients’ undergoing endovenous procedures and is committed to engaging venous specialists in this area of care. He has delivered invited presentations at international conferences including at SFP (2018), UIP Chapter meeting (2019) and CACVS (2020). He recently led the group that wrote the RSMVF advice on the subject.